You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

PENLAC Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Penlac, and when can generic versions of Penlac launch?

Penlac is a drug marketed by Valeant Bermuda and is included in one NDA.

The generic ingredient in PENLAC is ciclopirox. There are ten drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ciclopirox profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Penlac

A generic version of PENLAC was approved as ciclopirox by FOUGERA PHARMS on August 6th, 2004.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PENLAC?
  • What are the global sales for PENLAC?
  • What is Average Wholesale Price for PENLAC?
Summary for PENLAC
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 107
Clinical Trials: 2
Patent Applications: 5,007
Drug Prices: Drug price information for PENLAC
What excipients (inactive ingredients) are in PENLAC?PENLAC excipients list
DailyMed Link:PENLAC at DailyMed
Drug patent expirations by year for PENLAC
Drug Prices for PENLAC

See drug prices for PENLAC

Recent Clinical Trials for PENLAC

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
9305-9954 Quebec IncPhase 2
Rady Children's Hospital, San DiegoPhase 4

See all PENLAC clinical trials

US Patents and Regulatory Information for PENLAC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Bermuda PENLAC ciclopirox SOLUTION;TOPICAL 021022-001 Dec 17, 1999 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.